Pharmaceutical Contamination in U.S. Spreads to Germany, China is Prime Suspect

Contaminated batches of the blood thinning drug heparin that are potentially lethal have been discovered on the market in Germany. Producers have recalled supplies of heparin in the country in the past week following severe reactions to batches of the drug by up to 100 patients. The contamination cases in Germany follow the withdrawal at the end of February of contaminated batches of heparin in the U.S. that have been linked to as many as 800 adverse patient reactions and 19 patient deaths. The contaminated heparin used in the U.S. has been traced back to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers